# FDA recall Z-1490-2019

> **Change Healthcare Israel Ltd.** · Class II · device recall initiated 2019-03-25.

## Product

McKesson Cardiology Hemo

## Reason for recall

users are not notified of procedure medication discrepancies between the Vitals and Meds, the Procedure Notes and Patient Common Data screens in Horizon/McKesson Cardiology Hemo" (Hemo).  The discrepancy may also affect administered medication data in reports generated from Hemo or the Horizon/McKesson Cardiology Physician s Report as well as customers, who have implemented an outbound interface of procedure results.

## Distribution

Nationwide distribution to AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY,   OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WV, WY.      International distribution to Australia, Canada, Germany, Ireland, Israel, United Kingdom.

## Key facts

- **Recall number:** Z-1490-2019
- **Recalling firm:** Change Healthcare Israel Ltd.
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2019-03-25
- **Report date:** 2019-06-05
- **Termination date:** 2025-03-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Holon, N/A, Israel

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1490-2019

## Citation

> AI Analytics. FDA recall Z-1490-2019. Retrieved 2026-06-03 from https://api.ai-analytics.org/recall/Z-1490-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*